Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit all
about
Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein.Unresolved antiretroviral treatment management issues in HIV-infected childrenLack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patientsAntituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs.Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure.Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study.Long-Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of Efavirenz and 8-Hydroxy-Efavirenz in Ethiopian Patients.Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.When to start, what to start and other treatment controversies in pediatric HIV infection.Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review.
P2860
Q33797986-64C13957-9E43-4252-B7C6-186DBD63FFDCQ36781481-FB8BA20B-D79E-4461-916C-F2E59DEBFD88Q37690861-D8C4B422-1A55-4991-B156-8BE6BBC9DB18Q37810480-E0F0C593-CA22-4BBE-BAA9-14E4872D3E5DQ37835819-DC296306-B960-41E9-91F3-36F7F0817456Q37845854-2A5F0777-30E2-448E-B121-C697ECE7D866Q37866289-3C286462-7256-40F0-A75E-C96BA4F81977Q38861140-9F8DED2A-932F-42CF-A512-FAC2559C94E5Q39039468-C9233D14-3EAD-495A-85D2-A33AA2E1AFDCQ40694902-9218065C-864D-4D49-84C0-6C92E661ACBAQ42615157-7C73673B-8180-4B75-A1B3-533448F70C1EQ44986291-182FA765-408C-421B-954E-7C70C3A642ABQ52330065-C946283B-3BC7-4D1E-840D-FCE8940FD28B
P2860
Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit all
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dose adjustment of the non-nuc ...... apy: one size does not fit all
@ast
Dose adjustment of the non-nuc ...... apy: one size does not fit all
@en
Dose adjustment of the non-nuc ...... apy: one size does not fit all
@nl
type
label
Dose adjustment of the non-nuc ...... apy: one size does not fit all
@ast
Dose adjustment of the non-nuc ...... apy: one size does not fit all
@en
Dose adjustment of the non-nuc ...... apy: one size does not fit all
@nl
prefLabel
Dose adjustment of the non-nuc ...... apy: one size does not fit all
@ast
Dose adjustment of the non-nuc ...... apy: one size does not fit all
@en
Dose adjustment of the non-nuc ...... apy: one size does not fit all
@nl
P2860
P1476
Dose adjustment of the non-nuc ...... apy: one size does not fit all
@en
P2093
Awewura Kwara
Geetha Ramachandran
P2860
P356
10.1517/17425250903393752
P407
P577
2010-01-01T00:00:00Z